How does THEROS CancerTYPE ID help determine the primary site of origin?
The THEROS CancerTYPE ID test measures the expression pattern of 92 genes. The pattern of activity among these 92 genes is recognized as a “molecular fingerprint” which provides information beyond what can be seen under a microscope. This molecular fingerprint is compared with a reference database of 39 known cancer types. Based on this comparison, the original location of the tumor and the type of cancer can be identified with a high rate of accuracy.